Hisham N. Altayb

According to our database, Hisham N. Altayb authored at least 4 papers between 2022 and 2026.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of six.

2026

Evaluation of lawsone as a potential inhibitor of Staphylococcus aureus efflux pump mediated drugs resistance: An in-vitro and in-silico study.

Bochra Kouidhi, Ehab M. M. Ali, Tarek Zmantar, Sihem Bayar, Abdelsattar M. Omar, Salman Bakr Hosawi, Hisham N. Altayeb, Imran Kazmi, Mustafa Zeyadi, Kamel Chaieb

Comput. Biol. Chem., 2026

Predicting antimicrobial resistance in Staphylococcus aureus using machine learning: Insights from a five-year surveillance study.

Mohammed F. Aldawsari, Hisham N. Altayb, Ehssan Moglad

Comput. Biol. Chem., 2026

2024

Multi-targeted therapeutic potential of stigmasterol from the Euphorbia ammak plant in treating lung and breast cancer.

Othman A. Baothman, Ehab M. M. Ali, Salman Bakr Hosawi, Emadeldin Hassan E. Konozy, Isam M. Abu Zeid, Abrar Ahmad, Hisham N. Altayb

Comput. Biol. Chem., 2024

2022

Computational screening of natural compounds as putative quorum sensing inhibitors targeting drug resistance bacteria: Molecular docking and molecular dynamics simulations.

Kamel Chaieb, Bochra Kouidhi, Salman Bakr Hosawi, Othman A. Baothman, Mazin A. Zamzami, Hisham N. Altayeb

Comput. Biol. Medicine, 2022